White-blood-cell-containing allogeneic blood transfusion and postoperative infection or mortality: An updated meta-analysis

Vox Sanguinis

Volumn 92, Issue 3, 2007, Pages 224-232

  Vamvakas, E C ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Allogeneic blood transfusion; Immunomodulation; Immunosuppression; Leukofiltration; Leukoreduction; Mortality; Postoperative infection; White blood cell reduction

Indexed keywords

ABDOMINAL SURGERY; ANEURYSM SURGERY; ARTICLE; BLOOD STORAGE; BURN; CANCER SURGERY; COLORECTAL SURGERY; ELECTIVE SURGERY; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL SURGERY; HEART SURGERY; HUMAN; INFECTION RISK; LEUKOCYTE TRANSFUSION; MORTALITY; POSTOPERATIVE INFECTION; PRIORITY JOURNAL;

BLOOD COMPONENT REMOVAL; CELL SEPARATION; ERYTHROCYTE TRANSFUSION; HUMANS; IMMUNOLOGIC FACTORS; INFECTION; LEUKOCYTES; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS;

EID: 33847679328     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2006.00889.x     Document Type: Article

References (34)

1. Blumberg N: Deleterious clinical effects of transfusion immunomodulation: proved beyond reasonable doubt. Transfusion 2005:45 (Suppl.): 33S-39S
2. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97:1180-1195
3. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84:1703-1721
4. Nielsen HJ, Reimert CM, Pedersen AN, Brunner N, Edvarsen L, Dybkjaer E, Kehlet H, Skov PS: Time-dependent spontaneous release of white cell- and platelet-derived bioactive substances from stored human blood. Transfusion 1996; 36:960-965
5. Blumberg N, Zhao H, Messing S, Heal JM, Lyman GH: Misapplication of the intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Blood 2003; 102:562a
6. Fergusson D, Khanna MP, Tinmouth A, Hébert PC: Transfusion of leukoreduced red blood cells may decrease postoperative infections: two meta-analyses of randomized controlled trials. Can J Anaesth 2004; 51:417-424
7. Vamvakas EC: Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting. Transfus Med Rev 2002; 16:304-314
8. Vamvakas EC: WBC-containing allogeneic blood transfusion and mortality: a meta-analysis of randomized controlled trials. Transfusion 2003; 43:963-973
9. Vamvakas EC, Blajchman MA: Universal WBC reduction: the case for and against. Transfusion 2001; 41:691-712
10. Corwin HL, AuBuchon JP: Is leukoreduction of blood components for everyone? JAMA 2003; 289:1993-1995
11. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G, Mortensen J, Moller-Nielsen C, Hanberg-Sorensen F, Hokland M: Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79:513-516
12. Houbiers JGA, Brand A, van de Watering LMG, Hermans J, Verwey PJ, Bijnen AB, Pahlplatz P, Eeftinck Schattenkerk M, Wobbes T, de Vries JE: Randomized controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994; 344:573-578
13. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Quist N: Randomized comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion and complications after colorectal surgery. Lancet 1996; 348:841-845
14. van de Watering LMG, Hermans J, Houbiers JGA, van de Broeck PJ, Bouter H, Boer F, Harvey MS, Huysmans HA, Brand A: Beneficial effect of leukocyte depletion of transfused blood on post-operative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97:562-568
15. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M: Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176:462-466
16. Titlestad IL, Ebbesen LS, Ainsworth AP, Lillevang ST, Quist N, Georgsen J: Leukocyte-depletion of blood components does not significantly reduce the risk of infectious complications: Results of a double-blind, randomized study. Int J Colorectal Dis 2001; 16:147-153
17. Wallis JP, Chapman CE, Orr KE, Clark SC, Forty JR: Effect of WBC reduction of transfused RBCs on postoperative infection rates in cardiac surgery. Transfusion 2002; 42:1127-1134
18. van Hilten JA, van de Watering LMG, van Bockel JH, van de Velde CJH, Kievit J, Brand R, van den Hout WB, Geelkerken RH, Roumen RMH, Wesselink RMJ, Koopman-van Gemert A, Koning J, Brand A: Effects of transfusion with red cells filtered to remove leukocytes: randomized controlled trial in patients undergoing major surgery. BMJ 2004; 328:1281-1284
19. Bilgin YM, van de Watering LMG, Eijsman L, Versteegh MIM, Brand R, van Oers MHJ, Brand A: Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004; 109:2755-2760
20. Bracey AW, Radovancevick R, Nussimeier NA, LaRocco M, Vaughn WK, Cooper JR: Leukocyte-reduced blood in open-heart surgery patients: effects on outcome. Transfusion 2002; 42 (Suppl):5S
21. Boshkov LK, Furnary A, Morris C, Chien G, van Winkle D, Reik R: Prestorage leukoreduction of red cells in elective cardiac surgery: results of a double-blind randomized controlled trial. Blood 2004; 104:112a
22. Nathens AB, Nester TA, Rubenfeld GD, Nirula R, Gernsheimer TB: The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock 2006; 26:342-247
23. Nielsen HJ, Hammer J, Kraup AL, Nielsen LM, Reimert CM, Pedersen AN, Dybkjaer E, Partoft S, Alsbjorn B: Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns 1999; 25:162-170
24. Dzik WH, Anderson JK, O'Neill EM, Assman SF, Kalish LA, Stowell CP: A prospective, randomized clinical trial of universal WBC reduction. Transfusion 2002; 42:1114-1122
25. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
26. Cooper H, Hedges LV (eds): The Handbook of Research Synthesis. New York, NY, Russell Sage Foundation, 1994
27. Fransen E, Maessen J, Denterner M, Senden N, Buurman W: Impact of blood transfusion on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116:1233-1239
28. Kao KJ: Induction of humoral immune tolerance to major histocompatibility complex antigens by tranfusions of UV-B irradiated leukocytes. Blood 1996; 88:4375-4382
29. Vamvakas EC, Carven JH: Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion 1999; 39:701-710
30. Bordin JO, Bardossy L, Blajchman MA: Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of timing of the leukodepletion. Blood 1994; 84:344-348
31. Vamvakas E: Deleterious clinical effects of transfusion immunomodulation: proved beyond reasonable doubt. Transfusion 2006; 46:492-494
32. Fergusson D, Aaron SD, Guyatt G, Hébert P: Post-randomization exclusions: the intention-to-treat principle and excluding patients from the analysis. Br Med J 2002; 325:652-654
33. Kunz R, Guyatt G: Which patients to include in the analysis? Transfusion 2006; 46:881-884
34. Vamvakas EC: Multicenter randomized controlled trials in transfusion medicine. Transfus Med Rev 2000; 14:137-150